The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...

The Oncogenetics group have three sub-groups working alongside each other: the lab group of scientists and clinical fellows, the data group of scientists and administrators and the clinical group of ...

New research has provided insight into the biological mechanisms that may contribute to poor outcomes in certain cases of neuroblastoma – a cancer that develops in nerve tissue and primarily affects ...

The ICR takes part in a range of public events, including local science festivals, events at museums and community events where we share knowledge and ideas about our research with the public. As part ...

Dawn joined The Generations Study research team in 2004 with previous expertise in office management, recruitment, and communications. She joined to assist managing the study launch and overseeing the ...

The ICR, in collaboration with The Royal Marsden NHS Foundation Trust, has now taken delivery of the latest genome sequencing device, the NovaSeq X Plus. In this blog post, Mark Jones speaks with ...

Breast cancer remains a leading cause of cancer-related deaths globally, with triple-negative breast cancer (TNBC) presenting particular therapeutic challenges due to its aggressive nature and limited ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

Professor Trevor Graham's group harnesses artificial intelligence and the principles of evolution with the aim of improving cancer prevention, diagnosis and treatment. Trevor Graham is Professor of ...

In 2007, Graeme Chapman embarked on a mission to raise money for The Institute of Cancer Research. Eighteen years on, his annual fundraising event is still going strong and has raised more than £1.5m ...